News

HeartSciences to Present at the LD Micro Invitational XIV Conference

Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson is scheduled to present at the LD Micro Invitational XIV Conference on Tuesday April 9, 2024 at 5:00pm ET at the Sofitel New York. Mr. Simpson will also be hosting one-on-one meetings through the conference.

04/02/2024

Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today?

Heart Test Laboratories (NASDAQ: HSCS ) stock is falling hard on Wednesday after the medical technology company announced a secondary offering for its shares. Heart Test Laboratories notes that this is a resale of 34,684,859 shares of HSCS stock by a few shareholders.

03/06/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Heart Test Laboratories, Inc. (HSCS) a buy, sell, or hold?

Heart Test Laboratories, Inc. (HSCS) can sell. Click on Rating Page for detail.

What is Heart Test Laboratories, Inc.'s stock price?

The price of Heart Test Laboratories, Inc. (HSCS) is 0.0999 and it was updated on 2024-04-25 13:00:33.

Is Heart Test Laboratories, Inc. (HSCS) overvalued or undervalued?

Currently Heart Test Laboratories, Inc. (HSCS) is in undervalued.

News

From:

To:

News
Why Is Heart Test Laboratories (HSCS) Stock Up 43% Today? Heart Test Laboratories (NASDAQ: HSCS ) stock is rising higher on Wednesday without any clear news from the maker of cardiovascular diagnostic devices. There have been no new press releases or filings with the Securities and Exchange Commission that explain why HSCS stock is rising higher today. Wed, Nov. 15, 2023
Why Is Heart Test Laboratories (HSCS) Stock Moving Today? Heart Test Laboratories (NASDAQ: HSCS ) stock is on the move Thursday after announcing an agreement with the Icahn School of Medicine at Mount Sinai. This new agreement has Heart Test Laboratories' HeartSciences working with Icahn Mount Sinai to commercialize electrocardiographic artificial intelligence ( AI ) algorithms and assets. Thu, Sep. 21, 2023
HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson, will participate in a fireside chat at the upcoming Gilmartin Group Emerging Growth Showcase on Thursday, September 21, 2023, at 11:30 am ET. Tue, Sep. 12, 2023
HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023 Southlake, Texas, April 17, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a more valuable screening tool through the use of Artificial Intelligence (AI), today announces that CEO Andrew Simpson will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2023. Mon, Apr. 17, 2023
3 Tips for Using Technical Indicators to Find Penny Stocks to Buy Can these technical indicators help you make money with penny stocks? The post 3 Tips for Using Technical Indicators to Find Penny Stocks to Buy appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. Tue, Jan. 31, 2023

SEC Filings

SEC Filings
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 03/18/2024
Heart Test Laboratories, Inc. (HSCS) - EFFECT SEC Filings 03/14/2024
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 03/14/2024
Heart Test Laboratories, Inc. (HSCS) - 10-Q - Quarterly Report SEC Filings 03/14/2024
Heart Test Laboratories, Inc. (HSCS) - S-1 SEC Filings 03/05/2024
Heart Test Laboratories, Inc. (HSCS) - S-8 SEC Filings 02/26/2024
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 02/15/2024
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 01/31/2024
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 01/25/2024
Heart Test Laboratories, Inc. (HSCS) - DEFA14A SEC Filings 01/18/2024
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 01/18/2024
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 12/14/2023
Heart Test Laboratories, Inc. (HSCS) - 10-Q - Quarterly Report SEC Filings 12/14/2023
Heart Test Laboratories, Inc. (HSCS) - DEFA14A SEC Filings 12/13/2023
Heart Test Laboratories, Inc. (HSCS) - SC 13G SEC Filings 12/11/2023
Heart Test Laboratories, Inc. (HSCS) - DEF 14A SEC Filings 12/08/2023
Heart Test Laboratories, Inc. (HSCS) - D/A SEC Filings 12/07/2023
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 12/07/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 12/06/2023
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 12/04/2023
Heart Test Laboratories, Inc. (HSCS) - PRE 14A SEC Filings 11/28/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K/A - Current report SEC Filings 11/28/2023
Heart Test Laboratories, Inc. (HSCS) - SC 13G SEC Filings 11/27/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 11/27/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 11/21/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 11/17/2023
Heart Test Laboratories, Inc. (HSCS) - 424B5 SEC Filings 11/17/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 11/13/2023
Heart Test Laboratories, Inc. (HSCS) - 424B5 SEC Filings 11/13/2023
Heart Test Laboratories, Inc. (HSCS) - S-1/A SEC Filings 10/16/2023
Heart Test Laboratories, Inc. (HSCS) - 424B5 SEC Filings 10/04/2023
Heart Test Laboratories, Inc. (HSCS) - EFFECT SEC Filings 09/29/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/22/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/21/2023
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 09/20/2023
Heart Test Laboratories, Inc. (HSCS) - S-3 SEC Filings 09/18/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/14/2023
Heart Test Laboratories, Inc. (HSCS) - 10-Q - Quarterly Report SEC Filings 09/14/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/07/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 08/30/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 08/17/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 08/04/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 07/19/2023
Heart Test Laboratories, Inc. (HSCS) - 10-K - Current report SEC Filings 07/19/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 06/23/2023
Heart Test Laboratories, Inc. (HSCS) - SC 13D SEC Filings 06/14/2023
Heart Test Laboratories, Inc. (HSCS) - S-1 SEC Filings 06/07/2023
Heart Test Laboratories, Inc. (HSCS) - EFFECT SEC Filings 04/11/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 04/11/2023
Heart Test Laboratories, Inc. (HSCS) - S-1 SEC Filings 03/29/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 03/23/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 03/23/2023
Heart Test Laboratories, Inc. (HSCS) - 4 SEC Filings 03/22/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 03/16/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 03/16/2023
Heart Test Laboratories, Inc. (HSCS) - 10-Q - Quarterly Report SEC Filings 03/16/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K/A - Current report SEC Filings 03/14/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 03/14/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 03/13/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 03/13/2023
Heart Test Laboratories, Inc. (HSCS) - SC 13G SEC Filings 03/10/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 02/22/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 02/22/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 02/14/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 02/13/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 02/03/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 02/03/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 01/24/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 01/24/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 01/11/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 01/11/2023
Heart Test Laboratories, Inc. (HSCS) - 3 SEC Filings 01/06/2023
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 01/03/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 01/03/2023
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 12/27/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 12/23/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 12/22/2022
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 12/16/2022
Heart Test Laboratories, Inc. (HSCS) - 10-Q - Quarterly Report SEC Filings 12/15/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 10/26/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 10/19/2022
Heart Test Laboratories, Inc. (HSCS) - EFFECT SEC Filings 10/11/2022
Heart Test Laboratories, Inc. (HSCS) - EFFECT SEC Filings 10/11/2022
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 10/11/2022
Heart Test Laboratories, Inc. (HSCS) - S-1/A SEC Filings 10/06/2022
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 09/22/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/20/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/13/2022
Heart Test Laboratories, Inc. (HSCS) - S-1 SEC Filings 09/12/2022
Heart Test Laboratories, Inc. (HSCS) - 10-Q - Quarterly Report SEC Filings 09/12/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 09/09/2022
Heart Test Laboratories, Inc. (HSCS) - POS EX SEC Filings 08/05/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 08/05/2022
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 08/05/2022
Heart Test Laboratories, Inc. (HSCS) - 10-K - Current report SEC Filings 07/29/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 07/18/2022
Heart Test Laboratories, Inc. (HSCS) - 424B3 SEC Filings 07/18/2022
Heart Test Laboratories, Inc. (HSCS) - 3 SEC Filings 07/07/2022
Heart Test Laboratories, Inc. (HSCS) - 3 SEC Filings 07/06/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 06/23/2022
Heart Test Laboratories, Inc. (HSCS) - 424B4 SEC Filings 06/17/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K/A - Current report SEC Filings 06/16/2022
Heart Test Laboratories, Inc. (HSCS) - EFFECT SEC Filings 06/15/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K/A - Current report SEC Filings 06/15/2022
Heart Test Laboratories, Inc. (HSCS) - 8-K - Current report SEC Filings 06/15/2022
Heart Test Laboratories, Inc. (HSCS) - CERT SEC Filings 06/14/2022
Heart Test Laboratories, Inc. (HSCS) - 8-A12B SEC Filings 06/14/2022
Heart Test Laboratories, Inc. (HSCS) - S-1/A SEC Filings 06/13/2022
Heart Test Laboratories, Inc. (HSCS) - CORRESP SEC Filings 06/13/2022
Heart Test Laboratories, Inc. (HSCS) - S-1/A SEC Filings 06/10/2022
Heart Test Laboratories, Inc. (HSCS) - CORRESP SEC Filings 06/10/2022
Heart Test Laboratories, Inc. (HSCS) - UPLOAD SEC Filings 06/09/2022
Heart Test Laboratories, Inc. (HSCS) - S-1/A SEC Filings 06/06/2022
Heart Test Laboratories, Inc. (HSCS) - FWP SEC Filings 06/06/2022
Heart Test Laboratories, Inc. (HSCS) - CORRESP SEC Filings 06/06/2022
Heart Test Laboratories, Inc. (HSCS) - UPLOAD SEC Filings 06/01/2022
Heart Test Laboratories, Inc. (HSCS) - S-1 SEC Filings 05/17/2022
Heart Test Laboratories, Inc. (HSCS) - CORRESP SEC Filings 05/17/2022
Heart Test Laboratories, Inc. (HSCS) - UPLOAD SEC Filings 05/11/2022
Heart Test Laboratories, Inc. (HSCS) - DRS/A SEC Filings 04/20/2022
Heart Test Laboratories, Inc. (HSCS) - DRSLTR SEC Filings 04/19/2022
Heart Test Laboratories, Inc. (HSCS) - UPLOAD SEC Filings 04/04/2022
Heart Test Laboratories, Inc. (HSCS) - DRS SEC Filings 02/28/2022
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 12/28/2021
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 10/15/2021
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 02/19/2021
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 12/11/2019
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 11/07/2016
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 09/18/2015
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 07/17/2015
Heart Test Laboratories, Inc. (HSCS) - D SEC Filings 07/30/2009

Press Releases

StockPrice Release
Heartsciences announces grant of fundamental patent by the european patent office covering assessment of diastolic function of the heart using ai-ecg 04/24/2024
Heartsciences to present at the ld micro invitational xiv conference 04/02/2024
Heartsciences announces podium presentation at world congress of anesthesiologists on the utility of myovista® wavelet ecg for detection of left ventricular diastolic dysfunction in preoperative patients 03/26/2024
Heartsciences reports third quarter fiscal 2024 financial results 03/14/2024
Heartsciences' announces peer-reviewed publication evaluating use of myovista® technology to detect asymptomatic left ventricular dysfunction in patients with type 2 diabetes 03/12/2024
Heartsciences announces canada patent grant covering myovista® wavelet technology 03/06/2024
Heartsciences adds key advisor to its scientific advisory board 02/26/2024
Heartsciences expands its scientific advisory board 02/12/2024
Heartsciences appoints new scientific advisory board member 02/01/2024
Heartsciences announces results and adjournment of annual shareholder meeting 01/18/2024
Heartsciences reminds stockholders to vote at the upcoming annual shareholder meeting 01/03/2024
Heartsciences reports second quarter fiscal 2024 financial results 12/14/2023
Heartsciences receives fda confirmation for 510(k) clearance pathway 12/05/2023
Heartsciences' myovista® wavecgtm selected for heart screening of irish garda national police officers 11/13/2023
Heartsciences reports first quarter fiscal 2024 financial results 09/14/2023
Heartsciences to present at the gilmartin group emerging growth showcase 09/12/2023
Heartsciences named electrocardiography advancement specialists of the year 2023 - usa in the global health & pharma excellence awards 09/11/2023
Heartsciences signs distribution agreement with medphy technologies, mumbai, india 09/07/2023
Heartsciences signs distribution agreement with fj medical, denmark 08/31/2023
Heartsciences' myovista® wavecgtm selected to be used in irish heart screening evaluation 08/24/2023
Heartsciences announces further expansion of artificial intelligence (ai) patent portfolio 08/17/2023
Myovista wavecg goes into clinical use at the naya imaging center in denmark 07/27/2023
Heartsciences provides business update and reports fiscal 2023 financial results 07/19/2023
Heartsciences named as a top 10 healthcare artificial intelligence solutions provider 2023 by healthcare tech outlook magazine 05/17/2023
Heartsciences announces completion of patient enrollment for fda pivotal study of myovista wavecg 05/09/2023
Heartsciences to participate at the inaugural ef hutton global conference 05/08/2023
Heartsciences to participate in the benchmark company's virtual individual investor healthcare conference 05/02/2023
Heartsciences to present at the planet microcap showcase: vegas 2023 04/17/2023
Heartsciences ceo invited as featured guest on the big biz show, february 7 at 11:45 a.m. pacific time 02/07/2023
Heartsciences announces further internationalization of its patent portfolio 02/03/2023
Heartsciences provides business update and reports second quarter fiscal 2023 financial results 12/16/2022
Heartsciences announces major milestone with the issuance of cpt® codes by the american medical association for ecg ai analysis of cardiac dysfunction 10/19/2022
Heartsciences to present at microcap rodeo's windy city roundup conference on october 12th 10/06/2022
Heartsciences to participate and showcase the myovista at the inauguration ceremony of the center for innovation at rutgers robert wood johnson university hospital 09/12/2022
Heartsciences provides corporate update and reports fiscal 2022 financial results 08/01/2022
Heartsciences ceo to participate in the benzinga all access event on july 15th 07/13/2022

More Headlines

News
HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th SOUTHLAKE, TX / ACCESSWIRE / October 6, 2022 / Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG's clinical usefulness by detecting cardiac dysfunction, today announced that Andrew Simpson, Chairman and Chief Executive Officer of HeartSciences, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois. Mr. Simpson is scheduled to present on Wednesday, October 12th at 1:30 p.m. 10/06/2022

News

HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th

SOUTHLAKE, TX / ACCESSWIRE / October 6, 2022 / Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG's clinical usefulness by detecting cardiac dysfunction, today announced that Andrew Simpson, Chairman and Chief Executive Officer of HeartSciences, has been invited to present at the 2022 MicroCap Rodeo Windy City Roundup Conference, which is being held on October 12 - 13, 2022 in Chicago, Illinois. Mr. Simpson is scheduled to present on Wednesday, October 12th at 1:30 p.m.
10/06/2022

Unlock

HSCS Ratings Summary

HSCS Quant Ranking